Progression-free survival is a suboptimal predictor for overall survival among metastatic solid tumour clinical trials
Author:
Funder
National Cancer Institute, National Institutes of Health
Publisher
Elsevier BV
Subject
Cancer Research,Oncology
Reference31 articles.
1. What advanced cancer patients with limited treatment options know about clinical research: a qualitative study;Garrett;Support Care Canc,2017
2. Randomized controlled trials in the era of molecular oncology: methodology, biomarkers, and end points;Kay;Ann Oncol,2012
3. Surrogate endpoints in oncology: when are they acceptable for regulatory and clinical decisions, and are they currently overused?;Kemp;BMC Med,2017
4. Cancer drugs approved on the basis of a surrogate end point and subsequent overall survival: an analysis of 5 years of US Food and drug administration approvals;Kim;JAMA Intern Med,2015
5. Progression-free survival as an end-point in solid tumours–perspectives from clinical trials and clinical practice;Robinson;Eur J Canc,2014
Cited by 25 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Progression-Free Survival Should Not Be Used as a Primary End Point for Registration of Anticancer Drugs;Journal of Clinical Oncology;2023-11-10
2. Overall Survival After Treatment Failure Among Patients With Rectal Cancer;JAMA Network Open;2023-10-30
3. Progression-free survival as a primary end-point: Counting the cost;Qeios;2023-10-26
4. Challenges, Complexities, and Considerations in the Design and Interpretation of Late-Phase Oncology Trials;Seminars in Radiation Oncology;2023-10
5. The Role of Additional Staining in the Assessment of the Peritoneal Regression Grading Score (PRGS) in Peritoneal Metastasis of Gastric Origin;Applied Immunohistochemistry & Molecular Morphology;2023-09-13
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3